Forget the hyper-volatile, high-profile stock names. In this environment, lesser-known and less-exciting stocks are apt to ...

French drugmaker Sanofi said Monday it has agreed to acquire Blueprint Medicines for $9.5 billion, sending shares of the ...

But whether or not they realize it, many thousands of clones have already been produced as the cloning process has become ...

Do's husband? Discover what is known about her private marriage, how they met, and why she keeps her husband’s identity a ...

Growth investors have had to work harder than usual to find winners in 2025. With the S&P 500 essentially flat year to date ...

The Facebook and Instagram parent company already offers AI tools that generate variations of existing ads, tweak them, and ...

Three biomedical research projects conducted NCSU Wilson College of Textiles researchers demonstrate advances in health care ...

Such dramatic price swings aren't unusual in the biotechnology industry; in this case, disappointing data from an important ...

CRISPR Therapeutics has the potential to generate significant breakthroughs in gene editing. Regeneron's biggest growth ...

The curious minds at Aperture explore how tiny nanotechnologies are creating massive impacts in medicine, industry, and beyond.

The oncology giant will pay $1.5 billion to co-develop a BioNTech drug that targets the proteins PD-L1 and VEGF, following ...